发明名称 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
摘要 A compound of formula (I), pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof for the treatment of asthma, allergic rhinitis, COPD, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis or cancer.
申请公布号 ZA200500791(B) 申请公布日期 2006.11.29
申请号 ZA20050000791 申请日期 2005.01.26
申请人 ASTRAZENECA AB. 发明人 EBDEN, MARK RICHARD;BENNION, COLIN;BONNERT, ROGER VICTOR;MEGHANI, PREMJI;COOK, ANTONY RONALD
分类号 A61K;A61K31/505;A61K31/506;A61K31/5377;A61P;A61P1/04;A61P1/12;A61P3/10;A61P5/14;A61P7/04;A61P9/10;A61P11/00;A61P11/02;A61P11/06;A61P13/08;A61P13/12;A61P15/00;A61P15/06;A61P15/08;A61P17/00;A61P17/02;A61P17/04;A61P17/06;A61P17/08;A61P17/14;A61P19/02;A61P19/08;A61P19/10;A61P21/00;A61P21/04;A61P25/00;A61P25/06;A61P25/10;A61P25/14;A61P25/28;A61P27/02;A61P29/00;A61P31/04;A61P31/18;A61P35/00;A61P35/04;A61P37/02;A61P37/04;A61P37/06;A61P37/08;A61P43/00;C07D;C07D239/48;C07D239/69;C07D401/12;C07D403/12;C07D405/12;C07D409/12;C07D413/12;C07D413/14;C07D417/12 主分类号 A61K
代理机构 代理人
主权项
地址